#Drug Pricing Lobbying

Total 1 articles

Vacant executive chair in a boardroom overlooking Washington D.C.

Novo Nordisk US Public Affairs Chief Resigns Amid Rising Drug Price Pressure

Teal Hazel, Novo Nordisk's head of US public affairs, is resigning amid intense pressure over Ozempic and Wegovy pricing. Read more on the impact on lobbying strategy.

Jan 5, 2026